These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 190053)

  • 1. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism.
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
    Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
    Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II.
    Seki T; Yamamoto M; Kimura H; Tsuiki M; Ono M; Miki N; Takano K; Sato K
    Endocr J; 2010; 57(8):735-44. PubMed ID: 20505259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
    Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism.
    Stone MD; Hosking DJ; Garcia-Himmelstine C; White DA; Rosenblum D; Worth HG
    Bone; 1993; 14(5):727-35. PubMed ID: 8268047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase.
    Mizunashi K; Furukawa Y; Yoshinaga K
    Calcif Tissue Int; 1994 Mar; 54(3):186-94. PubMed ID: 8055364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone.
    Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T
    Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal responses to PTH in patients with hormone-resistant (pseudo) hypoparathyroidism.
    Moses AM; Breslau N; Coulson R
    Am J Med; 1976 Aug; 61(2):184-9. PubMed ID: 181985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
    Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
    Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
    Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K
    Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.
    Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C
    J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple pre- and postreceptor defects in pseudohypoparathyroidism (a multicenter study with twenty four patients).
    Radeke HH; Auf'mkolk B; Jüppner H; Krohn HP; Keck E; Hesch RD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):393-402. PubMed ID: 3001127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.